Adherence to tyrosine kinase inhibitor and clinical outcomes in patients with chronic myeloid leukemia

髓系白血病 酪氨酸激酶抑制剂 医学 回顾性队列研究 药物依从性 达沙替尼 内科学 肿瘤科 伊马替尼 癌症
作者
Fang Cheng,Zheng Cui,Qiang Li,Liu Wang,Weiming Li
出处
期刊:International Immunopharmacology [Elsevier BV]
卷期号:124: 110847-110847 被引量:5
标识
DOI:10.1016/j.intimp.2023.110847
摘要

To ensure optimal care for patients with chronic myeloid leukemia (CML), adherence to tyrosine kinase inhibitors (TKIs) has emerged as a critical component. The objective of this study was to assess the impact of TKIs adherence on clinical outcomes in a cohort of Chinese CML patients who received treatment with TKIs.This retrospective study employed a cross-sectional design utilizing questionnaires to assess adherence to TKIs in a sample of 398 patients diagnosed with CML. Adherence was measured using the Morisky Medication Adherence Scale (MMAS-8), which dichotomizes patients into low, medium, and high adherence groups.Of the patients included in this study, 34.2% were classified as highly adherent, with 43.2% and 22.6% of patients categorized as having medium and low adherence, respectively. Compared to the low-adherence group, patients in the medium- and high-adherence groups exhibited significantly higher rates of achieving major molecular response (MMR) and lower rates of switching TKIs. Moreover, patients who failed to adhere to TKIs treatment demonstrated significantly lower event-free survival and failure-free survival compared to those in the high-adherence group. Notably, regular molecular monitoring and utilization of the "CML Academy" mobile application were positively associated with increased TKI adherence. On the other hand, patients receiving third-generation or above first-line TKIs treatment displayed reduced adherence.The findings suggest that high adherence to TKIs treatment confers clinical benefits to patients with CML. Accordingly, the implementation of effective guidance and intervention measures aimed at promoting adherence to TKIs therapy in real-world settings is imperative.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zz2905发布了新的文献求助10
2秒前
一蓑烟雨完成签到,获得积分10
2秒前
2秒前
4秒前
崔崔发布了新的文献求助10
5秒前
ff不吃芹菜完成签到,获得积分10
6秒前
叶子完成签到,获得积分10
6秒前
唐唐完成签到,获得积分10
7秒前
123发布了新的文献求助10
7秒前
10秒前
朵朵完成签到,获得积分10
12秒前
发呆的小号完成签到 ,获得积分10
12秒前
充电宝应助原本采纳,获得10
14秒前
山260完成签到 ,获得积分10
14秒前
badada完成签到,获得积分10
14秒前
田様应助科研通管家采纳,获得10
16秒前
大模型应助科研通管家采纳,获得10
16秒前
科研通AI2S应助科研通管家采纳,获得10
16秒前
伶俐乐菱应助科研通管家采纳,获得10
17秒前
17秒前
17秒前
17秒前
shadow完成签到,获得积分10
18秒前
sen123完成签到,获得积分10
19秒前
123完成签到,获得积分20
20秒前
21秒前
NATURECATCHER完成签到,获得积分10
21秒前
温暖霸完成签到,获得积分10
21秒前
以筱完成签到,获得积分10
22秒前
NexusExplorer应助崔崔采纳,获得10
22秒前
CipherSage应助Passskd采纳,获得10
26秒前
27秒前
子睿完成签到,获得积分10
27秒前
背后雨柏完成签到 ,获得积分10
27秒前
28秒前
nanana发布了新的文献求助10
29秒前
量子星尘发布了新的文献求助10
29秒前
五月初夏完成签到,获得积分10
29秒前
hannah发布了新的文献求助10
32秒前
songvv完成签到,获得积分20
33秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038235
求助须知:如何正确求助?哪些是违规求助? 3575992
关于积分的说明 11374009
捐赠科研通 3305760
什么是DOI,文献DOI怎么找? 1819276
邀请新用户注册赠送积分活动 892662
科研通“疑难数据库(出版商)”最低求助积分说明 815022